Possible involvement of PPARγ in the regulation of basal channel opening of P2X7 receptor in cultured mouse astrocytes

Life Sciences

Volumn 84, Issue 23-24, 2009, Pages 825-831

  Nagasawa, Kazuki ^a   Miyaki, Jun ^a   Kido, Yuka ^a   Higashi, Youichirou ^a   Nishida, Kentaro ^a   Fujimoto, Sadaki ^a  

^a KYOTO PHARMACEUTICAL UNIVERSITY   (Japan)

Author keywords

Astrocyte; ATP; P2X7 receptor; PPAR ; YO PRO 1

Indexed keywords

2 CHLORO 5 NITROBENZANILIDE; ADENOSINE TRIPHOSPHATE; CIGLITAZONE; DELTA12 14 PROSTAGLANDIN J2; DYE; FLUFENAMIC ACID; INDOMETACIN; NONSTEROID ANTIINFLAMMATORY AGENT; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA AGONIST; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA ANTAGONIST; PROSTAGLANDIN SYNTHASE INHIBITOR; PURINERGIC P2X7 RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; ASTROCYTE; CELL CULTURE; CHANNEL GATING; FLUORESCENCE MICROSCOPY; IMMUNOCYTOCHEMISTRY; MOUSE; NONHUMAN; PROTEIN EXPRESSION; WESTERN BLOTTING;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ASTROCYTES; CELLS, CULTURED; ION CHANNELS; MICE; PPAR GAMMA; RATS; RATS, WISTAR; RECEPTORS, PURINERGIC P2;

EID: 67349159427     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lfs.2009.03.017     Document Type: Article

References (43)

1. Abdelrahman M., Sivarajah A., and Thiemermann C. Beneficial effects of PPAR-gamma ligands in ischemia-reperfusion injury, inflammation and shock. Cardiovascular Research 65 4 (2005) 772-781
2. Alloisio S., Aiello R., Ferroni S., and Nobile M. Potentiation of native and recombinant P2X7-mediated calcium signaling by arachidonic acid in cultured cortical astrocytes and human embryonic kidney 293 cells. Molecular Pharmacology 69 6 (2006) 1975-1983
3. Babbar N., Ignatenko N.A., Casero Jr. R.A., and Gerner E.W. Cyclooxygenase-independent induction of apoptosis by sulindac sulfone is mediated by polyamines in colon cancer. The Journal of Biological Chemistry 278 48 (2003) 47762-47775
4. Barbieri R., Alloisio S., Ferroni S., and Nobile M. Differential crosstalk between P2X7 and arachidonic acid in activation of mitogen-activated protein kinases. Neurochemistry International 53 6-8 (2008) 255-262
5. Berger J., and Moller D.E. The mechanisms of action of PPARs. Annual Review of Medicine 53 (2002) 409-435
6. Burgermeister E., and Seger R. MAPK kinases as nucleo-cytoplasmic shuttles for PPARgamma. Cell cycle (Georgetown, Tex.) 6 13 (2007) 1539-1548
7. Chattopadhyay N., Singh D.P., Heese O., Godbole M.M., Sinohara T., Black P.M., and Brown E.M. Expression of peroxisome proliferator-activated receptors (PPARS) in human astrocytic cells: PPARgamma agonists as inducers of apoptosis. Journal of Neuroscience Research 61 1 (2000) 67-74
8. Chen Y., Vartiainen N.E., Ying W., Chan P.H., Koistinaho J., and Swanson R.A. Astrocytes protect neurons from nitric oxide toxicity by a glutathione-dependent mechanism. Journal of Neurochemistry 77 6 (2001) 1601-1610
9. Cimini A., Benedetti E., Cristiano L., Sebastiani P., D'Amico M.A., D'Angelo B., and Di Loreto S. Expression of peroxisome proliferator-activated receptors (PPARs) and retinoic acid receptors (RXRs) in rat cortical neurons. Neuroscience 130 2 (2005) 325-337
10. Duan S., Anderson C.M., Keung E.C., Chen Y., Chen Y., and Swanson R.A. P2X7 receptor-mediated release of excitatory amino acids from astrocytes. Journal of Neuroscience 23 4 (2003) 1320-1328
11. 2+, and mitogen-activated protein kinase. Journal of Cellular Physiology 183 2 (2000) 155-162
12. 2 is a ligand for the adipocyte determination factor PPAR gamma. Cell 83 5 (1995) 803-812
13. Franke H., Gunther A., Grosche J., Schmidt R., Rossner S., Reinhardt R., Faber-Zuschratter H., Schneider D., and Illes P. P2X7 receptor expression after ischemia in the cerebral cortex of rats. Journal of Neuropathology and Experimental Neurology 63 7 (2004) 686-699
14. Gasparini L., Ongini E., and Wenk G. Non-steroidal anti-inflammatory drugs (NSAIDs) in Alzheimer's disease: old and new mechanisms of action. Journal of Neurochemistry 91 3 (2004) 521-536
15. 2 inhibits the inflammatory response in primary rat astrocytes via down-regulating multiple steps in phosphatidylinositol 3-kinase-Akt-NF-kappaB-p300 pathway independent of peroxisome proliferator-activated receptor gamma. Journal of Immunology 173 8 (2004) 5196-5208
16. Hatten M.E., Liem R.K., Shelanski M.L., and Mason C.A. Astroglia in CNS injury. Glia 4 2 (1991) 233-243
17. Heneka M.T., Sastre M., Dumitrescu-Ozimek L., Hanke A., Dewachter I., Kuiperi C., O'Banion K., Klockgether T., Van Leuven F., and Landreth G.E. Acute treatment with the PPARgamma agonist pioglitazone and ibuprofen reduces glial inflammation and Abeta1-42 levels in APPV717I transgenic mice. Brain 128 Pt 6 (2005) 1442-1453
18. 2 and thiazolidinediones transactivate epidermal growth factor and platelet-derived growth factor receptors in vascular smooth muscle cells. Biochemical and Biophysical Research Communications 323 2 (2004) 402-408
19. Iglesias R., Locovei S., Roque A.P., Alberto A.P., Dahl G., Spray D.C., and Scemes E. P2X7 receptor-Pannexin1 complex: pharmacology and signaling. American Journal of Physiology 295 3 (2008) C752-C760
20. 2 metabolite binds peroxisome proliferator-activated receptor gamma and promotes adipocyte differentiation. Cell 83 5 (1995) 813-819
21. Lehmann J.M., Lenhard J.M., Oliver B.B., Ringold G.M., and Kliewer S.A. Peroxisome proliferator-activated receptors alpha and gamma are activated by indomethacin and other non-steroidal anti-inflammatory drugs. The Journal of Biological Chemistry 272 6 (1997) 3406-3410
22. 7 receptor death complex. FEBS Letters 581 3 (2007) 483-488
23. Lovatt D., Sonnewald U., Waagepetersen H.S., Schousboe A., He W., Lin J.H., Han X., Takano T., Wang S., Sim F.J., Goldman S.A., and Nedergaard M. The transcriptsome and metabolic gene signature of protoplasmic astrocytes in the adult murine cortex. Journal of Neuroscience 24 45 (2007) 12255-12266
24. Luna-Medina R., Cortes-Canteli M., Alonso M., Santos A., Martinez A., and Perez-Castillo A. Regulation of inflammatory response in neural cells in vitro by thiadiazolidinones derivatives through peroxisome proliferator-activated receptor gamma activation. The Journal of Biological Chemistry 280 22 (2005) 21453-21462
25. Murgia M., Hanau S., Pizzo P., Rippa M., and Di Virgilio F. Oxidized ATP. An irreversible inhibitor of the macrophage purinergic P2Z receptor. The Journal of Biological Chemistry 268 11 (1993) 8199-8203
26. Nagai K., Nagasawa K., and Fujimoto S. Transport mechanisms for adenosine and uridine in primary-cultured rat cortical neurons and astrocytes. Biochemical and Biophysical Research Communications 334 4 (2005) 1343-1350
27. Nagasawa K., Aoki H., Yasuda E., Nagai K., Shimohama S., and Fujimoto S. Possible involvement of group I mGluRs in neuroprotective effect of theanine. Biochemical and Biophysical Research Communications 320 1 (2004) 116-122
28. Nagasawa K., Kawasaki F., Tanaka A., Nagai K., and Fujimoto S. Characterization of guanine and guanosine transport in primary cultured rat cortical astrocytes and neurons. Glia 55 14 (2007) 1397-1404
29. Nagasawa K., Escartin C., and Swanson R.A. Astrocyte cultures exhibit P2X7 receptor channel opening in the absence of exogenous ligands. Glia 57 6 (2009) 622-633
30. Nolan J.J., Ludvik B., Beerdsen P., Joyce M., and Olefsky J. Improvement in glucose tolerance and insulin resistance in obese subjects treated with troglitazone. The New England Journal of Medicine 331 18 (1994) 1188-1193
31. Norenberg M.D. Astrocyte responses to CNS injury. Journal of Neuropathology and Experimental Neurology 53 3 (1994) 213-220
32. North R.A. Molecular physiology of P2X receptors. Physiological Reviews 82 4 (2002) 1013-1067
33. North R.A., and Surprenant A. Pharmacology of cloned P2X receptors. Annual Review of Pharmacology and Toxicology 40 (2000) 563-580
34. Pelegrin P., and Surprenant A. Pannexin-1 mediates large pore formation and interleukin-1beta release by the ATP-gated P2X7 receptor. The EMBO Journal 25 21 (2006) 5071-5082
35. Piazza G.A., Alberts D.S., Hixson L.J., Paranka N.S., Li H., Finn T., Bogert C., Guillen J.M., Brendel K., Gross P.H., Sperl G., Ritchie J., Burt R.W., Ellsworth L., Ahnen D.J., and Pamukcu R. Sulindac sulfone inhibits azoxymethane-induced colon carcinogenesis in rats without reducing prostaglandin levels. Cancer Cesearch 57 14 (1997) 2909-2915
36. Ralevic V., and Burnstock G. Receptors for purines and pyrimidines. Pharmacological Reviews 50 3 (1998) 413-492
37. 2+ signaling. Journal of Neuroscience 26 5 (2006) 1378-1385
38. Surprenant A., Rassendren F., Kawashima E., North R.A., and Buell G. The cytolytic P2Z receptor for extracellular ATP identified as a P2X receptor (P2X7). Science (New York, N.Y) 272 5262 (1996) 735-738
39. Tegeder I., Pfeilschifter J., and Geisslinger G. Cyclooxygenase-independent actions of cyclooxygenase inhibitors. FASEB Journal 15 12 (2001) 2057-2072
40. Varley C.L., Stahlschmidt J., Lee W.C., Holder J., Diggle C., Selby P.J., Trejdosiewicz L.K., and Southgate J. Role of PPARgamma and EGFR signalling in the urothelial terminal differentiation programme. Journal of Cell Science 117 Pt 10 (2004) 2029-2036
41. Wick M., Hurteau G., Dessev C., Chan D., Geraci M.W., Winn R.A., Heasley L.E., and Nemenoff R.A. Peroxisome proliferator-activated receptor-gamma is a target of nonsteroidal anti-inflammatory drugs mediating cyclooxygenase-independent inhibition of lung cancer cell growth. Molecular Pharmacology 62 5 (2002) 1207-1214
42. Willson T.M., Lehmann J.M., and Kliewer S.A. Discovery of ligands for the nuclear peroxisome proliferator-activated receptors. Annals of the New York Academy of Sciences 804 (1996) 276-283
43. Zhang C., Baker D.L., Yasuda S., Makarova N., Balazs L., Johnson L.R., Marathe G.K., McIntyre T.M., Xu Y., Prestwich G.D., Byun H.S., Bittman R., and Tigyi G. Lysophosphatidic acid induces neointima formation through PPARgamma activation. The Journal of Experimental Medicine 199 6 (2004) 763-774